Does Vitamin D Deficiency Contribute to COVID-19 Severity?

In this systematic review, we assessed studies that probed at vitamin D deficiencies in both positive and negative COVID-19 cases. We compared vitamin D levels to see if there was a noticeable difference. Finally, through the review of several studies, we investigated whether more severe cases of CO...

Full description

Saved in:
Bibliographic Details
Published inCurrent developments in nutrition Vol. 6; no. Supplement_1; p. 207
Main Authors Kersh, Lydia, Geary, Kyla, Roberts, Michael, Daghigh, Farzaneh
Format Journal Article
LanguageEnglish
Published Elsevier Inc 01.06.2022
Oxford University Press
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:In this systematic review, we assessed studies that probed at vitamin D deficiencies in both positive and negative COVID-19 cases. We compared vitamin D levels to see if there was a noticeable difference. Finally, through the review of several studies, we investigated whether more severe cases of COVID-19 were correlated with low vitamin D levels. The mean and standard deviations of the vitamin D levels in patients who tested positive and negative for COVID-19 were analyzed. We used Practical Meta-Analysis Effect Size Calculator developed by David B. Wilson, Ph.D., George Mason University when looking at COVID-19 status and vitamin D (N = 50–80 nmol/L) deficient levels. In this systematic review, we measured mean, standard deviations, and 95% CI of many studies to determine if there is a consistent relationship between vitamin D levels and COVID-19. We also performed an independent sample t-test comparing non-survivors vs. survivors of COVID-19 and vitamin D levels, and when comparing moderate vs. severe COVID-19 symptoms and vitamin D levels. A few studies were compared to evaluate the difference in vitamin D levels (serum 25(OH)D, nmol/L) among those who tested positive for COVID-19 to those who tested negative. It was found that the average median serum 25(OH)D, nmol/L for patients who tested positive was 27.08 nmol/L (±0.58 SD, 95% CI: 1.88) and the average median of serum 25(OH)D, nmol/L for patients who tested negative was 48.67 nmol/L (±13.66 SD, 95% CI: 2.17) this difference was near significant (p = .059). When looking at the relationship between vitamin D levels and severity of COVID-19 progression the result was not statistically significant, t(df) = 0.84, p = .216. When comparing the average values of vitamin D level among those who survived COVID-19 vs. those who did not, the results were not statistically significant, t(269) = 0.17, p = .438. It is apparent that there is a trend found in relationships among those who test positive for COVID-19 and their vitamin D levels. There seems to be a correlation between vitamin D deficiency and likelihood of developing severe illness of COVID-19 when observing studies individually. However, when comparing studies on a larger scale it seems that the significant difference seems to fade. None.
ISSN:2475-2991
2475-2991
DOI:10.1093/cdn/nzac048.021